The New Hoorn Study

Not Applicable

• Conditions: Type 2 diabetes; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN31493512
• Lead Sponsor: VU University Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-03-24
• Last Update Posted: 9 May 2022
• Study Completion: 2050-01-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 2807

Inclusion Criteria

1. Men and women
2. Aged 40-65 years
3. From the municipal registry in the city of Hoorn

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> Current primary outcome measure as of 26/04/2022:<br><br> Disturbances in glucose metabolism is measured by fasting plasma glucose, 75-g Oral Glucose Tolerance Test and HbA1c at baseline and at the three follow-up measurements in 2010-2011 and 2013-2015 and 2021-2023.<br><br> _____<br><br> Previous primary outcome measure:<br><br> Disturbances in glucose metabolism is measured by fasting plasma glucose, 75-g Oral Glucose Tolerance Test and HbA1c at baseline and at the two follow-up measurements in 2010-2011 and 2013-2015.<br>

Secondary Outcome Measures

Name	Time	Method
<br> 1. Depressive symptoms are measured using CES-D questionnaire at baseline and 7 year follow up<br> 2. Quality of life is measured using questionnaires at baseline and 7 year follow up<br> 3. Cardiovascular complications of diabetes are measured by a check of the medical records of the participants every three years<br>